Assignee
OMEGA THERAPEUTICS INC
US·1 granted patent·7 pending applications·0 citations·filing 2020–2024
Top patents by PatentIndex Score
8 records- 0156US2024344061A1COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4alpha) GENE EXPRESSIONOMEGA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0252US2024254462A1Compositions and methods for modulating secreted frizzled receptor protein 1 (sfrp1) gene expressionOMEGA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0346US11987791B2Compositions and methods for modulating hepatocyte nuclear factor 4-alpha (HNF4α) gene expressionOMEGA THERAPEUTICS INC·Filed 2020·Granted May 21, 2024·0 cites·37 claims
- 0441US2022288237A1Compositions and methods for modulating apolipoprotein b (apob) gene expressionOMEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0540US2023114151A1Compositions and methods for modulating forkhead box p3 (foxp3) gene expressionOMEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0637US2024197636A1Tissue-specific nucleic acid delivery by mixed cationic lipid particlesOMEGA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0733US2024115730A1Tissue-specific nucleic acid delivery by 1,2-dioleoyl-3-trimethylammonium-propane (dotap) lipid nanoparticlesOMEGA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0830US2022348893A1Methods and compositions for modulating frataxin expression and treating friedrich's ataxiaOMEGA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →